ETON
Eton Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural
Analyst sentiment is strongly bullish with a 100% Strong Buy consensus from three coverage providers, yet historical win rates vary (50% for Craig-Hallum, 0% for B. Riley and HC Wainwright). Fund-flow data show a good score of 7.89/10, with positive trends across block, medium, large, and extra-large flows, partially offset by a negative small-flow trend. This indicates robust institutional interest but also highlights some retail skepticism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-14
InstitutionCraig-Hallum
Times predicted2
Historical Win Rate50.0%
What is the analyst consensus for ETON?
- ETON holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.41/10 (Netural).
